The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer (AEGC).
 
Annette Van Zweeden
No Relationships to Disclose
 
Cees Van Groeningen
No Relationships to Disclose
 
Richard Honeywell
No Relationships to Disclose
 
Rita Ruijter
No Relationships to Disclose
 
Carolien H. Smorenburg
No Relationships to Disclose
 
Giuseppe Giaccone
Consulting or Advisory Role - Astex Pharmaceuticals; Boehringer Ingelheim; Celgene; Clovis Oncology; Inivata
Research Funding - AstraZeneca; Karyopharm Therapeutics
 
Henk M.W. Verheul
Consulting or Advisory Role - Boehringer Ingelheim (Inst)
Research Funding - Amgen (Inst); Immunovo (Inst); Roche (Inst); Vitromics (Inst)
 
Godefridus J. Peters
No Relationships to Disclose
 
Hans J. Van Der Vliet
No Relationships to Disclose